Literature DB >> 26825391

Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool.

Marjolijn C J Jongmans1, Jan L C M Loeffen2, Esmé Waanders3, Peter M Hoogerbrugge4, Marjolijn J L Ligtenberg3, Roland P Kuiper3, Nicoline Hoogerbrugge3.   

Abstract

Genetic predisposition for childhood cancer is under diagnosed. Identifying these patients may lead to therapy adjustments in case of syndrome-related increased toxicity or resistant disease and syndrome-specific screening programs may lead to early detection of a further independent malignancy. Cancer surveillance might also be warranted for affected relatives and detection of a genetic mutation can allow for reproductive counseling. Here we present an easy-to-use selection tool, based on a systematic review of pediatric cancer predisposing syndromes, to identify patients who may benefit from genetic counseling. The selection tool involves five questions concerning family history, the type of malignancy, multiple primary malignancies, specific features and excessive toxicity, which results in the selection of those patients that may benefit from referral to a clinical geneticist.
Copyright © 2016 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cancer susceptibility; Childhood cancer; Congenital anomalies; Dysmorphisms; Family history; Selection tool

Mesh:

Year:  2016        PMID: 26825391     DOI: 10.1016/j.ejmg.2016.01.008

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  32 in total

Review 1.  T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?

Authors:  Emma Kroeze; Jan L C Loeffen; Vera M Poort; Jules P P Meijerink
Journal:  Blood Adv       Date:  2020-07-28

Review 2.  Germline Genetic Predisposition to Hematologic Malignancy.

Authors:  Elissa Furutani; Akiko Shimamura
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

Review 3.  Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr.

Authors:  Garrett M Brodeur; Kim E Nichols; Sharon E Plon; Joshua D Schiffman; David Malkin
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531

Review 4.  Introduction to cancer genetic susceptibility syndromes.

Authors:  Rose B McGee; Kim E Nichols
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 5.  Imaging of cancer predisposition syndromes.

Authors:  Mary-Louise C Greer
Journal:  Pediatr Radiol       Date:  2018-08-04

Review 6.  Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Authors:  Sebastian Zahnreich; Heinz Schmidberger
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

7.  Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.

Authors:  Andishe Attarbaschi; Elisa Carraro; Leila Ronceray; Mara Andrés; Shlomit Barzilai-Birenboim; Simon Bomken; Laurence Brugières; Birgit Burkhardt; Francesco Ceppi; Alan K S Chiang; Monika Csoka; Alina Fedorova; Janez Jazbec; Edita Kabickova; Jan Loeffen; Karin Mellgren; Natalia Miakova; Olga Moser; Tomoo Osumi; Apostolos Pourtsidis; Charlotte Rigaud; Anne Uyttebroeck; Wilhelm Woessmann; Marta Pillon
Journal:  Leukemia       Date:  2020-05-11       Impact factor: 11.528

8.  Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents.

Authors:  Andishe Attarbaschi; Elisa Carraro; Oussama Abla; Shlomit Barzilai-Birenboim; Simon Bomken; Laurence Brugieres; Eva Bubanska; Birgit Burkhardt; Alan K S Chiang; Monika Csoka; Alina Fedorova; Janez Jazbec; Edita Kabickova; Zdenka Krenova; Jelena Lazic; Jan Loeffen; Georg Mann; Felix Niggli; Natalia Miakova; Tomoo Osumi; Leila Ronceray; Anne Uyttebroeck; Denise Williams; Wilhelm Woessmann; Grazyna Wrobel; Marta Pillon
Journal:  Haematologica       Date:  2016-08-11       Impact factor: 9.941

9.  Using family history forms in pediatric oncology to identify patients for genetic assessment.

Authors:  A Hamilton; E Smith; J Hamon; E Tomiak; M Bassal; S L Sawyer
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

10.  The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.

Authors:  C Kelaidi; V Tzotzola; S Polychronopoulou
Journal:  Fam Cancer       Date:  2021-06-15       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.